Total Funding
75
34
Total FundingSeries A raised
Growth Score
-8 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
581288
SynapCell is a preclinical contract research organization, providing solutions for the therapeutic potential of CNS candidates in epilepsy.
Corinne Roucard: Chief Executive Officer
Yann Roche: Chief Operating Officer
About the Company
SynapCell is a French simplified joint-stock company founded in April 2005 and located at Grenoble, France.
The mission of SynapCell is to bring added-value to CNS drug development by creating solutions for preclinical evaluation of CNS therapeutics and providing consulting, pre-designed and customized programs to experts in the biopharmaceutical
industry.
